Poseida Therapeutics Inc
NASDAQ:PSTX
Poseida Therapeutics Inc
NASDAQ:PSTX
Price:
9.5
USD
-0.63%
Market Cap:
$926m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Poseida Therapeutics Inc
NASDAQ:PSTX
|
US |
|
G
|
Greenidge Generation Holdings Inc
NASDAQ:GREE
|
US |
|
J
|
Jiahe Foods Industry Co Ltd
SSE:605300
|
CN |
|
MEG Energy Corp
TSX:MEG
|
CA |
|
Lectra SA
PAR:LSS
|
FR |
|
Clearford Water Systems Inc
XTSX:CLI
|
CA |
|
G
|
GeoCrystal Ltd
ASX:GDC
|
AU |
|
H
|
Hilan Ltd
TASE:HLAN
|
IL |
|
M
|
mPlus Corp
KOSDAQ:259630
|
KR |
|
S
|
Seaboard Corp
F:S0V
|
US |
|
C
|
Cloudwalk Technology Co Ltd
SSE:688327
|
CN |
|
Goodtech ASA
OSE:GOD
|
NO |
|
V
|
Vinhomes JSC
VN:VHM
|
VN |
|
CI Financial Corp
TSX:CIX
|
CA |
|
S
|
SV Investment Corp
KOSDAQ:289080
|
KR |
|
CalAmp Corp
OTC:CAMPQ
|
US |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PSTX's stock price target?
Not Available
PSTX doesn't have any price targets made by Wall Street professionals.
What is Poseida Therapeutics Inc's Revenue forecast?
Projected CAGR
13%
13%
For the last 6 years the
compound annual growth rate for
Poseida Therapeutics Inc's revenue is
67%.
The projected
CAGR
for the next 4 years is
13%.
